MicroRNAs and cardiac fibrosis: A comprehensive update on mechanisms and consequences

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Regenerative Medicine

Background:

• Fibrosis, an overactivation of fibroblasts, impairs tissue regeneration, particularly in cardiac muscle.
• Cardiac fibrosis leads to excessive extracellular matrix buildup, potentially causing arrhythmias and heart failure.
• MicroRNAs (miRNAs) are small non-coding RNAs implicated in maintaining tissue homeostasis.

Purpose of the Study:

• To review the current understanding of miRNA involvement in myocardial fibrosis.
• To highlight miRNA modulation of cardiac fibrosis and identify potential therapeutic targets.

Main Methods:

• Comprehensive literature review of recent studies on miRNAs and cardiac fibrosis.
• Analysis of miRNA roles in regulating extracellular matrix deposition and TGF-beta signaling.
• Identification of miRNA targets relevant to therapeutic interventions.

Main Results:

• Evidence shows miRNAs are significantly altered in myocardial fibrosis.
• Specific miRNAs regulate the TGF-beta signaling pathway, a key factor in fibrosis.
• miRNAs demonstrate potential for both diagnostic and therapeutic applications in cardiac fibrosis.

Conclusions:

• miRNAs are critical regulators of myocardial fibrosis.
• Targeting specific miRNAs presents a promising therapeutic strategy for cardiac fibrosis.
• Further research into miRNA mechanisms can advance treatments for heart failure.